Cargando…
Two Beats One: Osteosarcoma Therapy with Light-Activated and Chemo-Releasing Keratin Nanoformulation in a Preclinical Mouse Model
Osteosarcoma treatment is moving towards more effective combination therapies. Nevertheless, these approaches present distinctive challenges that can complicate the clinical translation, such as increased toxicity and multi-drug resistance. Drug co-encapsulation within a nanoparticle formulation can...
Autores principales: | Martella, Elisa, Dozza, Barbara, Ferroni, Claudia, Obeyok, Clement Osuru, Guerrini, Andrea, Tedesco, Daniele, Manet, Ilse, Sotgiu, Giovanna, Columbaro, Marta, Ballestri, Marco, Martini, Lucia, Fini, Milena, Lucarelli, Enrico, Varchi, Greta, Duchi, Serena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8950553/ https://www.ncbi.nlm.nih.gov/pubmed/35336051 http://dx.doi.org/10.3390/pharmaceutics14030677 |
Ejemplares similares
-
Functionalized Keratin as Nanotechnology-Based Drug Delivery System for the Pharmacological Treatment of Osteosarcoma
por: Martella, Elisa, et al.
Publicado: (2018) -
Mesenchymal stromal cells mediated delivery of photoactive nanoparticles inhibits osteosarcoma growth in vitro and in a murine in vivo ectopic model
por: Lenna, Stefania, et al.
Publicado: (2020) -
Anticancer activity of paclitaxel-loaded keratin nanoparticles in two-dimensional and perfused three-dimensional breast cancer models
por: Foglietta, Federica, et al.
Publicado: (2018) -
HSA-Binding Prodrugs-Based Nanoparticles Endowed with Chemo and Photo-Toxicity against Breast Cancer
por: Rapozzi, Valentina, et al.
Publicado: (2022) -
Pheophorbide A and Paclitaxel Bioresponsive Nanoparticles as Double-Punch Platform for Cancer Therapy
por: Moret, Francesca, et al.
Publicado: (2021)